PTX 0.00% 4.0¢ prescient therapeutics limited

Ann: PTX Appoints Former Array BioPharma Executive to Key Role, page-8

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 13,386 Posts.
    lightbulb Created with Sketch. 162
    Very experienced professional appointed , PTX in 2019 could be the ASX's star performer in the Biotec sector imo.


    Dr Winkler said, “Even though it is currently a small company, Prescient has unique and exciting drugs in development. I am excited to join a small and passionate team and contribute to the important work of developing new treatments for people with cancer.”
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.0¢
Change
0.000(0.00%)
Mkt cap ! $32.21M
Open High Low Value Volume
4.0¢ 4.1¢ 4.0¢ $22.35K 558.4K

Buyers (Bids)

No. Vol. Price($)
6 221774 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 860576 3
View Market Depth
Last trade - 14.51pm 19/11/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.